Adiponectin expression in CSF has also been studied in other neurodegenerative diseases, such as Alzheimer’s disease and mild cognitive impairment; it has been found to be positively correlated with disease markers such as Aβ42 and cognitive function [34, 35]. Here, ADIPOQ is linked to Cognitive impairment.